|
Hey Cheri & Birgitta!
I'm following this discussion with great interest, and really appreciate Birgitta'a summary of the various effects of thalidomide.
Birgitta, have you run across any studies that suggest which MDS patients might be most likely to respond to treatment with thalidomide? Or is that question -- like with the use of immunosuppressants -- still being worked out?
Take care!
Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at www.greghankins.com
|